Investor · San Francisco, CA

Thomas Van Dyck

Open Thomas in the network graph →

Filings

9

SEC Form D

Connections

39

co-filers

Capital

—

across filings

Active

Jul 2010

to Jun 2014

Most-connected co-filers (39)

Gregory B. Stock · Boise, ID9 shared Sir William Young · San Francisco, CA8 shared Brook Byers · MENLO PARK, CA4 shared William Baquet · New York, NY4 shared John P. Martinsen · Minneapolis, MN4 shared Kate Adams · Boston, MA4 shared John W. Walsh · MINNEAPOLIS, MN4 shared Lawrence Leisure · CHICAGO, IL4 shared Jack Oliver · SOUTH SAN FRANCISCO, CA4 shared Patrick W. Agemian · George Town, Grand Cayman, Cayman Islands4 shared Sally Corning · ALBUQUERQUE, NM4 shared William Hagstrom · MENLO PARK, CA4 shared Caroline Popper · Seattle, WA3 shared Jeffrey S. Froikin-Gordon · Washington, Washington, D.C.3 shared Kristine Eppes · Houston, TX3 shared R. S. Egginton · MINNEAPOLIS, MN3 shared Bill Salisbury · Austin, TX3 shared Ralph K. Snyderman · Durham, NC3 shared Jennifer S. West · Spokane, WA3 shared Sue Siegel · South San Francisco, CA3 shared Jack Van Hulst · San Francisco, CA3 shared George Rehm · South San Francisco, CA3 shared L. S. Cave · Atlanta, GA3 shared Pravin Chaturvedi · San Francisco, CA2 shared

Recent filings (9)

NAPO PHARMACEUTICALS INCJun 2014 · 9 co-filers$138K Crescendo Bioscience, Inc.Jan 2013 · 17 co-filers$28.5M NAPO PHARMACEUTICALS INCOct 2011 · 13 co-filers$5.0M Crescendo Bioscience, Inc.Sep 2011 · 15 co-filers$25.0M NAPO PHARMACEUTICALS INCJun 2011 · 13 co-filers$6.0M Crescendo Bioscience, Inc.Jun 2011 · 15 co-filers$40.0M NAPO PHARMACEUTICALS INCOct 2010 · 13 co-filers$8.9M Crescendo Bioscience, Inc.Jul 2010 · 12 co-filers$42.6M NAPO PHARMACEUTICALS INCJul 2009 · 9 co-filers$500K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Thomas in the interactive graph →